06-08-2026 21:49 via drugs.com

FDA Approves First Drug for Full Range of Narcolepsy Symptoms

THURSDAY, Aug. 6, 2026-- The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults.Orzeyful marks the first medicine approval for the full range of symptoms associated with...

Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality

Socioeconomic Inequalities Tied to Functional Aging

Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay

First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus

Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease

Study IDs Neurobiological Roots of Sensory Over-Responsivity

2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening

Endometriosis Tied to Higher Risk for Developing Type 2 Diabetes

Older Adults Limit Movements With Rising Temperatures

Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors

Physician Normalization of Symptoms May Lead Patients to Not Seek Treatment

Subclinical Cardiac Dysfunction Linked to Neurodegeneration in APOE-ε4 Carriers

Dexamethasone Eye Drops Can Reduce Progression to ROP Requiring Treatment

Deramiocel Can Safely Slow Progression in Advanced Duchenne Muscular Dystrophy

Desktop versie

FDA Approves First Drug for Full Range of Narcolepsy Symptoms

Pharmaceutical Industry news